(Q33823950)

English

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Cardiovascular safety of ustekinumab in patients with moderate to severe psoriasis: results of integrated analyses of data from phase II and III clinical studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

circulatory system

1 reference

based on heuristic

inferred from title

Christopher Griffiths

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

K Reich

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

R G Langley

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M Lebwohl

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

P Szapary

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

C Guzzo

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

N Yeilding

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

S Li

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

M-C Hsu

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

language of work or name

0 references

publication date

1 April 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

British Journal of Dermatology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

164

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

862-872

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Pathogenesis and clinical features of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The psychosocial and occupational impact of chronic skin disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The psychosocial burden of psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Epidemiology of psoriatic arthritis in the population of the United States.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

National Psoriasis Foundation clinical consensus on psoriasis comorbidities and recommendations for screening.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Psoriatic arthritis: epidemiology, clinical features, course, and outcome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Cardiovascular disease and classic cardiovascular risk factors in patients with psoriasis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Heart disease in psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The risk of stroke in patients with psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The risk of mortality in patients with psoriasis: results from a population-based study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Psoriasis is independently associated with psychiatric morbidity and adverse cardiovascular risk factors, but not with cardiovascular events in a population-based sample.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Long-term efficacy of biologics in the treatment of psoriasis: what do we really know?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Current status and new developments in the treatment of psoriasis and psoriatic arthritis with biological agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Psoriasis and systemic inflammatory diseases: potential mechanistic links between skin disease and co-morbid conditions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Pathogenic mechanisms shared between psoriasis and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 52-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 2)

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Ustekinumab, a human interleukin 12/23 monoclonal antibody, for psoriatic arthritis: randomised, double-blind, placebo-controlled, crossover trial.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Exact and efficient inference procedure for meta-analysis and its application to the analysis of independent 2 x 2 tables with all available data but without artificial continuity correction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Heart Disease and Stroke Statistics--2010 Update: A Report From the American Heart Association

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Cytokines in atherosclerosis: pathogenic and regulatory pathways

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Association analysis of IL-12B and IL-23R polymorphisms in myocardial infarction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

What effects might anti-TNFalpha treatment be expected to have on cardiovascular morbidity and mortality in rheumatoid arthritis? A review of the role of TNFalpha in cardiovascular pathophysiology.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Blockade of interleukin-12 function by protein vaccination attenuates atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Safety and efficacy of ABT-874, a fully human interleukin 12/23 monoclonal antibody, in the treatment of moderate to severe chronic plaque psoriasis: results of a randomized, placebo-controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2011.10257.X

21 January 2018

Identifiers

10.1111/J.1365-2133.2011.10257.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21332467%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33823950&oldid=1951446474"